All In MedTech

FDA Clearance Tracker · P060025-S002

ATS 3F AORTIC BIOPROSTHESIS MODEL 1000

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 21, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 21, 2019

Approved

Time to decision

3,920 days

Received Nov 26, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P060025-S002
Device name
ATS 3F AORTIC BIOPROSTHESIS MODEL 1000
Applicant location
Minneapolis, MN
Received
Nov 26, 2008
Decided
Aug 21, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P060025

Device type

Device class
Class III

Every decision under product code LWR

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.